Pagerols, Mireia
Prat, Raquel
Rivas, Cristina
Español-Martín, Gemma
Puigbó, Júlia
Pagespetit, Èlia
Haro, Josep Maria
Ramos-Quiroga, Josep Antoni
Casas, Miquel
Bosch, Rosa
Article History
Received: 3 September 2021
Accepted: 2 March 2022
First Online: 11 March 2022
Competing interests
: J.M.H. has received economic compensation for participating in an advisory board organized by Eli Lilly and Co. J.A.R.Q. has served on the speakers' bureau and acted as consultant for BGaze, Bial, Ferrer, Janssen, Laboratorios Rubió, Lundbeck, Medice, Novartis, Ono, Shionogi, Shire, Sincrolab, and Takeda. He has received travel awards from Janssen, Medice, Shire, and Takeda for participating in psychiatric meetings. The Department of Psychiatry chaired by J.A.R.Q. has received unrestricted educational and research support from BGaze, Fundació Barça, Fundació Probitas, Janssen, Laboratorios Rubió, Lundbeck, Nesplora, Oryzon, Psious, Roche, Rovi, and Shire in the past two years. M.C. has received travel grants and research support from Eli Lilly and Co., Janssen, and Shire. He has been on the advisory board and served as a consultant for Eli Lilly and Co., Janssen, and Shire. The other authors declare no conflict of interest.